von Zastrow Mark
Department of Psychiatry, University of California, San Francisco, Room N212E Genentech Hall, 600 16th Street, San Francisco, CA 94143-2140, USA.
Neuropharmacology. 2004;47 Suppl 1:286-92. doi: 10.1016/j.neuropharm.2004.05.007.
Opiate drugs such as morphine and heroin are among the most effective analgesics known but are also highly addictive. The clinical utility of opiates is limited by adaptive changes in the nervous system occurring after prolonged or repeated drug administration. These adaptations are believed to play an important role in the development of physiological tolerance and dependence to opiates, and to contribute to additional changes underlying the complex neurobehavioral syndrome of drug addiction. All of these adaptive changes are initiated by the binding of opiate drugs to a subfamily of G protein-coupled receptors that are also activated by endogenously produced opioid neuropeptides. It is increasingly evident that opiate-induced adaptations occur at multiple levels in the nervous system, beginning with regulation of opioid receptors themselves and extending to a complex network of direct and indirect modifications of "downstream" signaling machinery. Efforts in my laboratory are directed at understanding the biochemical and cell biological basis of opiate adaptations. So far, we have focused primarily on adaptations occurring at the level of opioid receptors themselves. These studies have contributed to defining a set of membrane trafficking mechanisms by which the number and functional activity of opioid receptors are controlled. The role of these mechanisms in affecting adaptation of "downstream" neurobiological substrates, and in mediating opiate-induced changes in whole-animal physiology and behavior, are exciting questions that are only beginning to be explored.
诸如吗啡和海洛因之类的阿片类药物是已知最有效的镇痛药之一,但也极易成瘾。阿片类药物的临床效用受到长期或反复给药后神经系统适应性变化的限制。这些适应性变化被认为在阿片类药物生理耐受性和依赖性的发展中起重要作用,并促成药物成瘾复杂神经行为综合征背后的其他变化。所有这些适应性变化都是由阿片类药物与G蛋白偶联受体亚家族结合引发的,内源性产生的阿片样神经肽也可激活该亚家族。越来越明显的是,阿片类药物诱导的适应性变化发生在神经系统的多个层面,从阿片受体本身的调节开始,延伸到对“下游”信号传导机制的直接和间接修饰的复杂网络。我实验室的工作旨在了解阿片类药物适应性变化的生化和细胞生物学基础。到目前为止,我们主要关注阿片受体本身水平上发生的适应性变化。这些研究有助于确定一组膜转运机制,通过这些机制可控制阿片受体的数量和功能活性。这些机制在影响“下游”神经生物学底物的适应性以及介导阿片类药物引起的全动物生理和行为变化中的作用,是令人兴奋的问题,目前才刚刚开始探索。